| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ethanol | 57 | 2023 | 893 | 5.830 |
Why?
|
| Alcohol Drinking | 38 | 2023 | 805 | 4.980 |
Why?
|
| Alcoholism | 27 | 2023 | 1109 | 2.570 |
Why?
|
| Mice, Inbred C57BL | 38 | 2020 | 2791 | 1.390 |
Why?
|
| Stress, Psychological | 11 | 2021 | 824 | 1.230 |
Why?
|
| Mice | 50 | 2023 | 8474 | 1.190 |
Why?
|
| Central Nervous System Depressants | 14 | 2018 | 182 | 1.010 |
Why?
|
| Prefrontal Cortex | 13 | 2023 | 640 | 0.980 |
Why?
|
| Substance Withdrawal Syndrome | 9 | 2019 | 435 | 0.960 |
Why?
|
| Animals | 66 | 2023 | 20881 | 0.940 |
Why?
|
| Social Isolation | 4 | 2014 | 40 | 0.880 |
Why?
|
| Inhalation Exposure | 3 | 2016 | 33 | 0.820 |
Why?
|
| Doxazosin | 1 | 2020 | 20 | 0.730 |
Why?
|
| Conditioning, Operant | 6 | 2015 | 241 | 0.720 |
Why?
|
| Behavior, Animal | 10 | 2020 | 470 | 0.720 |
Why?
|
| Stress, Physiological | 2 | 2020 | 215 | 0.710 |
Why?
|
| Swimming | 3 | 2019 | 38 | 0.700 |
Why?
|
| Self Administration | 8 | 2020 | 419 | 0.660 |
Why?
|
| Brain | 12 | 2020 | 2176 | 0.640 |
Why?
|
| Gene Regulatory Networks | 6 | 2020 | 94 | 0.630 |
Why?
|
| Anxiety | 7 | 2022 | 422 | 0.590 |
Why?
|
| Male | 49 | 2023 | 37321 | 0.550 |
Why?
|
| Binge Drinking | 4 | 2021 | 50 | 0.540 |
Why?
|
| Orexin Receptor Antagonists | 1 | 2016 | 3 | 0.540 |
Why?
|
| Drinking Behavior | 1 | 2016 | 20 | 0.530 |
Why?
|
| Aminopyridines | 1 | 2016 | 26 | 0.530 |
Why?
|
| Neurons | 7 | 2023 | 881 | 0.520 |
Why?
|
| Receptors, Opioid, kappa | 4 | 2022 | 37 | 0.520 |
Why?
|
| Piperidines | 1 | 2016 | 123 | 0.510 |
Why?
|
| Central Amygdaloid Nucleus | 3 | 2022 | 16 | 0.480 |
Why?
|
| Environment | 2 | 2014 | 115 | 0.480 |
Why?
|
| Nucleus Accumbens | 8 | 2021 | 417 | 0.450 |
Why?
|
| Avoidance Learning | 4 | 2012 | 58 | 0.450 |
Why?
|
| Drug Tolerance | 1 | 2012 | 80 | 0.400 |
Why?
|
| Reinforcement Schedule | 3 | 2014 | 59 | 0.390 |
Why?
|
| Alcohol Withdrawal Seizures | 1 | 2011 | 12 | 0.380 |
Why?
|
| Neuronal Plasticity | 3 | 2020 | 274 | 0.370 |
Why?
|
| Dose-Response Relationship, Drug | 10 | 2020 | 1745 | 0.340 |
Why?
|
| Small-Conductance Calcium-Activated Potassium Channels | 3 | 2020 | 27 | 0.340 |
Why?
|
| Species Specificity | 5 | 2016 | 303 | 0.330 |
Why?
|
| Mice, Inbred DBA | 6 | 2016 | 120 | 0.310 |
Why?
|
| Brain-Derived Neurotrophic Factor | 2 | 2019 | 124 | 0.290 |
Why?
|
| Transcriptome | 2 | 2020 | 164 | 0.270 |
Why?
|
| Computational Biology | 4 | 2020 | 190 | 0.260 |
Why?
|
| Female | 25 | 2023 | 38074 | 0.260 |
Why?
|
| Synaptic Transmission | 5 | 2020 | 236 | 0.250 |
Why?
|
| Disease Models, Animal | 9 | 2022 | 2550 | 0.240 |
Why?
|
| Dopamine | 3 | 2016 | 474 | 0.240 |
Why?
|
| Analysis of Variance | 3 | 2016 | 1040 | 0.240 |
Why?
|
| Sex Factors | 4 | 2018 | 1266 | 0.240 |
Why?
|
| MicroRNAs | 2 | 2019 | 447 | 0.220 |
Why?
|
| Phosphodiesterase 4 Inhibitors | 1 | 2023 | 4 | 0.220 |
Why?
|
| Corticosterone | 3 | 2014 | 51 | 0.220 |
Why?
|
| Neurotransmitter Agents | 3 | 2018 | 102 | 0.220 |
Why?
|
| Motivation | 2 | 2014 | 561 | 0.220 |
Why?
|
| Pregnanolone | 2 | 2014 | 6 | 0.210 |
Why?
|
| Psoriasis | 1 | 2023 | 46 | 0.210 |
Why?
|
| Dynorphins | 2 | 2022 | 69 | 0.210 |
Why?
|
| Basolateral Nuclear Complex | 1 | 2023 | 28 | 0.200 |
Why?
|
| Receptors, Oxytocin | 1 | 2021 | 9 | 0.190 |
Why?
|
| Narcotic Antagonists | 2 | 2020 | 184 | 0.190 |
Why?
|
| Quinazolines | 1 | 2021 | 70 | 0.190 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 2 | 2020 | 266 | 0.180 |
Why?
|
| Mice, Inbred Strains | 2 | 2014 | 181 | 0.180 |
Why?
|
| Recurrence | 4 | 2019 | 948 | 0.180 |
Why?
|
| Nicotine | 1 | 2003 | 350 | 0.180 |
Why?
|
| Septal Nuclei | 1 | 2020 | 31 | 0.170 |
Why?
|
| Oxytocin | 1 | 2021 | 124 | 0.170 |
Why?
|
| 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer | 1 | 2018 | 5 | 0.160 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2019 | 114 | 0.160 |
Why?
|
| Nerve Tissue Proteins | 1 | 2020 | 290 | 0.160 |
Why?
|
| Gene Expression Regulation | 4 | 2016 | 1293 | 0.160 |
Why?
|
| Biogenic Monoamines | 1 | 2018 | 18 | 0.160 |
Why?
|
| Dendritic Spines | 2 | 2017 | 76 | 0.150 |
Why?
|
| RNA, Messenger | 2 | 2022 | 1664 | 0.150 |
Why?
|
| Age Factors | 3 | 2014 | 1864 | 0.150 |
Why?
|
| Multiprotein Complexes | 1 | 2017 | 56 | 0.150 |
Why?
|
| Receptors, Biogenic Amine | 1 | 2017 | 4 | 0.140 |
Why?
|
| Drug-Seeking Behavior | 2 | 2017 | 213 | 0.140 |
Why?
|
| G Protein-Coupled Inwardly-Rectifying Potassium Channels | 1 | 2017 | 8 | 0.140 |
Why?
|
| Naltrexone | 1 | 2018 | 195 | 0.140 |
Why?
|
| Pregnenolone | 1 | 2016 | 4 | 0.140 |
Why?
|
| Laser Capture Microdissection | 1 | 2016 | 3 | 0.140 |
Why?
|
| Allostasis | 1 | 2016 | 6 | 0.140 |
Why?
|
| Protein Array Analysis | 1 | 2016 | 32 | 0.140 |
Why?
|
| Alcohol-Related Disorders | 1 | 2017 | 95 | 0.140 |
Why?
|
| Sequence Analysis, RNA | 1 | 2016 | 34 | 0.140 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2017 | 118 | 0.140 |
Why?
|
| Alcohol-Induced Disorders, Nervous System | 1 | 2016 | 11 | 0.140 |
Why?
|
| Potassium Channels | 1 | 2016 | 55 | 0.130 |
Why?
|
| Action Potentials | 4 | 2018 | 223 | 0.130 |
Why?
|
| Limbic System | 1 | 2016 | 106 | 0.130 |
Why?
|
| Pharmacogenetics | 1 | 2016 | 47 | 0.130 |
Why?
|
| Sucrose | 1 | 2016 | 58 | 0.130 |
Why?
|
| Dopaminergic Neurons | 1 | 2016 | 46 | 0.130 |
Why?
|
| Restraint, Physical | 1 | 2016 | 59 | 0.130 |
Why?
|
| Reward | 1 | 2017 | 201 | 0.130 |
Why?
|
| Glucagon-Like Peptide-1 Receptor | 1 | 2015 | 20 | 0.130 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2017 | 167 | 0.130 |
Why?
|
| Globus Pallidus | 1 | 2015 | 64 | 0.120 |
Why?
|
| Hippocampus | 3 | 2019 | 471 | 0.120 |
Why?
|
| Dark Adaptation | 1 | 2014 | 39 | 0.120 |
Why?
|
| Withholding Treatment | 1 | 2014 | 35 | 0.120 |
Why?
|
| Receptors, Dopamine D4 | 1 | 2014 | 10 | 0.120 |
Why?
|
| Phosphodiesterase Inhibitors | 1 | 2013 | 28 | 0.110 |
Why?
|
| Cohort Studies | 2 | 2016 | 2358 | 0.110 |
Why?
|
| Microinjections | 3 | 2020 | 130 | 0.110 |
Why?
|
| Exploratory Behavior | 1 | 2014 | 79 | 0.110 |
Why?
|
| Alcoholic Intoxication | 3 | 1999 | 61 | 0.110 |
Why?
|
| Receptors, Dopamine D2 | 1 | 2014 | 109 | 0.110 |
Why?
|
| Cerebral Cortex | 1 | 2016 | 415 | 0.110 |
Why?
|
| Executive Function | 1 | 2014 | 106 | 0.110 |
Why?
|
| Time Factors | 4 | 2016 | 4655 | 0.110 |
Why?
|
| Body Weight | 1 | 2014 | 554 | 0.100 |
Why?
|
| Extinction, Psychological | 1 | 2014 | 240 | 0.100 |
Why?
|
| Administration, Inhalation | 4 | 2020 | 187 | 0.100 |
Why?
|
| Smell | 3 | 1999 | 131 | 0.100 |
Why?
|
| Pyridines | 1 | 2013 | 261 | 0.100 |
Why?
|
| Gene Expression Profiling | 3 | 2020 | 498 | 0.100 |
Why?
|
| Mice, Inbred C3H | 1 | 2011 | 134 | 0.090 |
Why?
|
| Weaning | 1 | 2010 | 12 | 0.090 |
Why?
|
| Motor Activity | 4 | 2003 | 621 | 0.090 |
Why?
|
| Cognition | 1 | 2014 | 513 | 0.090 |
Why?
|
| Affect | 2 | 2022 | 218 | 0.090 |
Why?
|
| Receptors, Muscarinic | 1 | 2009 | 44 | 0.080 |
Why?
|
| Weight Gain | 2 | 2008 | 135 | 0.080 |
Why?
|
| Axons | 1 | 2009 | 139 | 0.080 |
Why?
|
| Housing, Animal | 1 | 2008 | 16 | 0.080 |
Why?
|
| Drug Administration Schedule | 2 | 2008 | 567 | 0.080 |
Why?
|
| Excitatory Postsynaptic Potentials | 2 | 2020 | 87 | 0.080 |
Why?
|
| Pregnancy, Animal | 2 | 1999 | 27 | 0.080 |
Why?
|
| Immune System | 1 | 2008 | 63 | 0.080 |
Why?
|
| Tissue Culture Techniques | 2 | 2018 | 62 | 0.070 |
Why?
|
| Rats | 9 | 2014 | 5300 | 0.070 |
Why?
|
| Animals, Newborn | 5 | 1999 | 396 | 0.070 |
Why?
|
| Hypothalamo-Hypophyseal System | 2 | 2012 | 150 | 0.070 |
Why?
|
| Pituitary-Adrenal System | 2 | 2012 | 138 | 0.070 |
Why?
|
| Random Allocation | 2 | 2020 | 442 | 0.070 |
Why?
|
| Models, Animal | 2 | 2019 | 252 | 0.070 |
Why?
|
| Receptors, AMPA | 2 | 2017 | 99 | 0.070 |
Why?
|
| Pyrazoles | 2 | 2019 | 190 | 0.070 |
Why?
|
| Substance-Related Disorders | 1 | 2015 | 1242 | 0.060 |
Why?
|
| Patch-Clamp Techniques | 2 | 2017 | 204 | 0.060 |
Why?
|
| Corpus Striatum | 2 | 2019 | 279 | 0.060 |
Why?
|
| In Vitro Techniques | 2 | 2016 | 765 | 0.060 |
Why?
|
| Injections, Intraperitoneal | 1 | 2003 | 89 | 0.060 |
Why?
|
| Cotinine | 1 | 2003 | 40 | 0.060 |
Why?
|
| Transcription, Genetic | 2 | 2016 | 562 | 0.060 |
Why?
|
| Linear Models | 2 | 2016 | 521 | 0.060 |
Why?
|
| Rats, Long-Evans | 2 | 2014 | 203 | 0.060 |
Why?
|
| Body Temperature | 1 | 2003 | 116 | 0.060 |
Why?
|
| Thalidomide | 1 | 2023 | 24 | 0.050 |
Why?
|
| Rats, Wistar | 6 | 1999 | 371 | 0.050 |
Why?
|
| Animals, Suckling | 2 | 1999 | 7 | 0.050 |
Why?
|
| Alcohol Abstinence | 1 | 2022 | 23 | 0.050 |
Why?
|
| Paraventricular Hypothalamic Nucleus | 1 | 2021 | 15 | 0.050 |
Why?
|
| Corticotropin-Releasing Hormone | 1 | 2012 | 79 | 0.050 |
Why?
|
| Odorants | 2 | 1999 | 52 | 0.050 |
Why?
|
| Blotting, Western | 2 | 2017 | 954 | 0.050 |
Why?
|
| Norepinephrine | 1 | 2012 | 276 | 0.050 |
Why?
|
| Mice, Mutant Strains | 2 | 2015 | 166 | 0.050 |
Why?
|
| Hypothalamus | 1 | 2021 | 78 | 0.050 |
Why?
|
| Histones | 1 | 2021 | 111 | 0.050 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2012 | 186 | 0.050 |
Why?
|
| Epigenesis, Genetic | 1 | 2021 | 163 | 0.040 |
Why?
|
| Touch | 1 | 1999 | 25 | 0.040 |
Why?
|
| Association Learning | 1 | 1999 | 36 | 0.040 |
Why?
|
| Anxiety Disorders | 1 | 2022 | 426 | 0.040 |
Why?
|
| Postpartum Period | 1 | 1999 | 67 | 0.040 |
Why?
|
| Genetic Techniques | 1 | 2018 | 32 | 0.040 |
Why?
|
| Humans | 8 | 2023 | 68618 | 0.040 |
Why?
|
| Receptors, Neurotransmitter | 1 | 2018 | 31 | 0.040 |
Why?
|
| Milk | 1 | 1998 | 43 | 0.040 |
Why?
|
| Collagen Type VI | 1 | 2017 | 5 | 0.040 |
Why?
|
| Macaca | 1 | 2017 | 24 | 0.040 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2017 | 25 | 0.040 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 1 | 2017 | 32 | 0.040 |
Why?
|
| Genetic Vectors | 1 | 2018 | 312 | 0.040 |
Why?
|
| Glutamic Acid | 1 | 2020 | 332 | 0.040 |
Why?
|
| Actin Cytoskeleton | 1 | 2017 | 37 | 0.040 |
Why?
|
| Cluster Analysis | 1 | 2018 | 219 | 0.040 |
Why?
|
| Learning | 1 | 1999 | 186 | 0.040 |
Why?
|
| Gestational Age | 1 | 1998 | 389 | 0.040 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 1 | 2017 | 56 | 0.040 |
Why?
|
| Inhibitory Postsynaptic Potentials | 1 | 2017 | 25 | 0.040 |
Why?
|
| 17-alpha-Hydroxypregnenolone | 1 | 2016 | 2 | 0.040 |
Why?
|
| Phenylenediamines | 1 | 2016 | 16 | 0.030 |
Why?
|
| Ventral Striatum | 1 | 2016 | 5 | 0.030 |
Why?
|
| Genome-Wide Association Study | 1 | 2017 | 240 | 0.030 |
Why?
|
| Membrane Transport Modulators | 1 | 2016 | 23 | 0.030 |
Why?
|
| Compulsive Behavior | 1 | 2016 | 12 | 0.030 |
Why?
|
| Carbamates | 1 | 2016 | 41 | 0.030 |
Why?
|
| Embryonic and Fetal Development | 1 | 1996 | 74 | 0.030 |
Why?
|
| Steroids | 1 | 2016 | 84 | 0.030 |
Why?
|
| Pregnancy | 4 | 2009 | 2334 | 0.030 |
Why?
|
| Genetic Variation | 1 | 2016 | 220 | 0.030 |
Why?
|
| Apamin | 1 | 2015 | 13 | 0.030 |
Why?
|
| Models, Genetic | 1 | 2016 | 161 | 0.030 |
Why?
|
| Protein Subunits | 1 | 2015 | 99 | 0.030 |
Why?
|
| Genetic Association Studies | 1 | 2015 | 103 | 0.030 |
Why?
|
| Potassium Channel Blockers | 1 | 2015 | 32 | 0.030 |
Why?
|
| Gene Expression | 1 | 2017 | 770 | 0.030 |
Why?
|
| Quantitative Trait Loci | 1 | 2015 | 35 | 0.030 |
Why?
|
| Functional Neuroimaging | 1 | 2015 | 82 | 0.030 |
Why?
|
| Microarray Analysis | 1 | 2015 | 63 | 0.030 |
Why?
|
| Organ Specificity | 1 | 2015 | 167 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2016 | 320 | 0.030 |
Why?
|
| Choice Behavior | 1 | 2015 | 85 | 0.030 |
Why?
|
| Alleles | 1 | 2015 | 386 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 2017 | 597 | 0.030 |
Why?
|
| Molecular Targeted Therapy | 1 | 2015 | 170 | 0.030 |
Why?
|
| Electric Stimulation | 1 | 2015 | 218 | 0.030 |
Why?
|
| Base Sequence | 1 | 2016 | 1015 | 0.030 |
Why?
|
| Receptor, Metabotropic Glutamate 5 | 1 | 2014 | 51 | 0.030 |
Why?
|
| Central Nervous System Agents | 1 | 2014 | 37 | 0.030 |
Why?
|
| Maze Learning | 1 | 2014 | 138 | 0.030 |
Why?
|
| Photic Stimulation | 1 | 2014 | 229 | 0.030 |
Why?
|
| Membrane Proteins | 1 | 2017 | 617 | 0.030 |
Why?
|
| Benzamides | 1 | 2014 | 156 | 0.030 |
Why?
|
| Genotype | 1 | 2015 | 786 | 0.030 |
Why?
|
| Neuropsychological Tests | 1 | 2015 | 517 | 0.030 |
Why?
|
| Psychomotor Performance | 1 | 2014 | 213 | 0.030 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2014 | 211 | 0.030 |
Why?
|
| Peptides | 1 | 2015 | 455 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2015 | 1553 | 0.020 |
Why?
|
| Biomarkers | 1 | 2016 | 1593 | 0.020 |
Why?
|
| Analgesics, Opioid | 1 | 2016 | 498 | 0.020 |
Why?
|
| Aging | 1 | 1996 | 911 | 0.020 |
Why?
|
| Tetrazolium Salts | 1 | 2009 | 36 | 0.020 |
Why?
|
| Carbachol | 1 | 2009 | 34 | 0.020 |
Why?
|
| Muscarinic Agonists | 1 | 2009 | 17 | 0.020 |
Why?
|
| Culture Media, Conditioned | 1 | 2009 | 78 | 0.020 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 2009 | 106 | 0.020 |
Why?
|
| Liver | 1 | 2015 | 1118 | 0.020 |
Why?
|
| Receptor, Muscarinic M1 | 1 | 2009 | 17 | 0.020 |
Why?
|
| Coloring Agents | 1 | 2009 | 66 | 0.020 |
Why?
|
| Receptors, GABA-A | 1 | 2009 | 89 | 0.020 |
Why?
|
| Thiazoles | 1 | 2009 | 95 | 0.020 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2009 | 175 | 0.020 |
Why?
|
| Microdialysis | 1 | 2008 | 147 | 0.020 |
Why?
|
| Population Control | 1 | 2008 | 3 | 0.020 |
Why?
|
| Population Density | 1 | 2008 | 18 | 0.020 |
Why?
|
| Tissue Distribution | 1 | 2008 | 282 | 0.020 |
Why?
|
| Protein Kinase C | 1 | 2009 | 270 | 0.020 |
Why?
|
| Amniotic Fluid | 2 | 1999 | 30 | 0.020 |
Why?
|
| Astrocytes | 1 | 2009 | 270 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2008 | 532 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2009 | 1174 | 0.020 |
Why?
|
| Chromatography, Gas | 2 | 1996 | 31 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2015 | 2223 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2009 | 2673 | 0.010 |
Why?
|
| Young Adult | 1 | 2015 | 5717 | 0.010 |
Why?
|
| Phenotype | 1 | 2006 | 947 | 0.010 |
Why?
|
| Maternal Behavior | 1 | 1999 | 29 | 0.010 |
Why?
|
| Conditioning, Classical | 1 | 1999 | 57 | 0.010 |
Why?
|
| Locomotion | 1 | 1999 | 135 | 0.010 |
Why?
|
| Habituation, Psychophysiologic | 1 | 1998 | 22 | 0.010 |
Why?
|
| Osmolar Concentration | 1 | 1998 | 134 | 0.010 |
Why?
|
| Middle Aged | 1 | 2015 | 21147 | 0.010 |
Why?
|
| Adult | 1 | 2015 | 21403 | 0.010 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 1998 | 154 | 0.010 |
Why?
|
| Electroshock | 1 | 1996 | 36 | 0.010 |
Why?
|
| Maternal-Fetal Exchange | 1 | 1996 | 57 | 0.010 |
Why?
|
| Sodium Chloride | 1 | 1996 | 136 | 0.010 |
Why?
|
| Fetal Blood | 1 | 1996 | 131 | 0.010 |
Why?
|